Key Takeaways
- • UC Davis launched the Aggie Venture Accelerator (AVA) in partnership with The March Group, a thematic venture capital firm, welcoming three inaugural cohort companies: SinewUS, Pharm to Food, and ThriveSpan Labs.
- • The three selected startups represent distinct life science verticals: tendon-specific health diagnostics (SinewUS), analytical tools for food and health product development (Pharm to Food), and personalized metabolic wellness diagnostics for GLP-1 users (ThriveSpan Labs).
- • AVA provides intensive mentorship, structured entrepreneurial training, strategic guidance, and industry connections designed to bridge the gap between academic research discovery and commercial venture development at UC Davis.
- • The accelerator is positioned as part of UC Davis' broader innovation ecosystem strategy, building on the university's research excellence to accelerate life science and biotechnology commercialization.
Summary
UC Davis' Innovation and Economic Development Office announced the inaugural cohort of the Aggie Venture Accelerator (AVA), a newly launched program developed in partnership with The March Group, a thematic venture capital firm focused on life sciences and biotechnology. The three selected startups—SinewUS, Pharm to Food, and ThriveSpan Labs—were chosen through a competitive application process and represent the diversity of research commercialization opportunities emerging from UC Davis' research portfolio.
Each selected startup addresses distinct market opportunities within the life sciences sector. SinewUS has developed a tendon-specific health platform targeting musculoskeletal health. Pharm to Food offers advanced analytical tools that provide actionable product development insights for food and health companies. ThriveSpan Labs is building a personalized metabolic wellness platform with diagnostics specifically designed to support users of GLP-1 medications, capitalizing on the rapidly growing weight-loss and metabolic health market.
The accelerator program provides early-stage founders with comprehensive support services including intensive mentorship, structured entrepreneurial training, strategic guidance, and access to industry networks. These resources are designed to help translate promising technologies from the university's research pipeline into scalable commercial ventures. George Baxter, UC Davis' chief innovation and economic development officer, characterized the launch as "a transformative moment for our university," emphasizing AVA's role in converting "breakthrough discoveries into enduring companies."
The Aggie Venture Accelerator represents UC Davis' strategic commitment to closing the commercialization gap between academic research and market-ready ventures. By leveraging the university's research strengths across life sciences, agriculture, food innovation, and health, AVA aims to create a sustainable pipeline of venture-backed companies addressing complex problems at the intersection of human, animal, and environmental health. This initiative builds on the university's established reputation for research excellence while positioning the institution as a source of venture-quality deal flow for institutional investors and venture capital firms focused on the life sciences sector.
Each selected startup addresses distinct market opportunities within the life sciences sector. SinewUS has developed a tendon-specific health platform targeting musculoskeletal health. Pharm to Food offers advanced analytical tools that provide actionable product development insights for food and health companies. ThriveSpan Labs is building a personalized metabolic wellness platform with diagnostics specifically designed to support users of GLP-1 medications, capitalizing on the rapidly growing weight-loss and metabolic health market.
The accelerator program provides early-stage founders with comprehensive support services including intensive mentorship, structured entrepreneurial training, strategic guidance, and access to industry networks. These resources are designed to help translate promising technologies from the university's research pipeline into scalable commercial ventures. George Baxter, UC Davis' chief innovation and economic development officer, characterized the launch as "a transformative moment for our university," emphasizing AVA's role in converting "breakthrough discoveries into enduring companies."
The Aggie Venture Accelerator represents UC Davis' strategic commitment to closing the commercialization gap between academic research and market-ready ventures. By leveraging the university's research strengths across life sciences, agriculture, food innovation, and health, AVA aims to create a sustainable pipeline of venture-backed companies addressing complex problems at the intersection of human, animal, and environmental health. This initiative builds on the university's established reputation for research excellence while positioning the institution as a source of venture-quality deal flow for institutional investors and venture capital firms focused on the life sciences sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.